CVS vs TPCS · P/E 16, rev $402.07B vs rev $34.0M
CVS Health Corp (CVS) versus TechPrecision Corporation Common stock (TPCS) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
TechPrecision Corporation Common stock (TPCS) is a metal fabrication company listed on NASDAQ.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported TPCS revenue for 2025-03-31 was $34.0M. Net income was -$2.7M. Revenue was up 7.7% from 2024-03-31 to 2025-03-31. TPCS currently screens at market cap $34.5M.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. TPCS currently screens at market cap $34.5M.
Not investment advice. Open the CVS and TPCS stock pages for the full models.
Not investment advice.